Marsh & Mclennan Companies (MRSH) EBITDA (2009 - 2026)

Marsh & Mclennan Companies (MRSH) has reported EBITDA for 18 consecutive years, with $1.9 billion the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, EBITDA rose 3.83% year-over-year to $1.9 billion; the trailing twelve-month figure through Jun 2026 stood at $6.0 billion (down 0.69% YoY), and the FY2025 full-year result was $6.2 billion, up 6.98% from the prior year.
• EBITDA rose to $1.9 billion in Q2 2026 per MRSH's latest filing, from $1.8 billion in the prior quarter.
• Across five years, EBITDA topped out at $2.0 billion in Q1 2025 and bottomed at $680.0 million in Q4 2022.
• Historically, EBITDA has averaged $1.4 billion across 5 years, with a median of $1.4 billion in 2022.
• The sharpest annual moves came in 2022 and 2023: EBITDA plunged 31.03% in 2022, then soared 62.21% in 2023.
• Over 5 years, EBITDA stood at $680.0 million in 2022, then jumped by 62.21% to $1.1 billion in 2023, then advanced by 3.54% to $1.1 billion in 2024, then climbed by 6.74% to $1.2 billion in 2025, then surged by 55.78% to $1.9 billion in 2026.
• According to Business Quant data, EBITDA over the past three periods registered $1.9 billion, $1.8 billion, and $1.2 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.